insurance coverage tirzepatide Medicaid of and Spending on GLP-1s Tirzepatide Costs, Insurance & Savings

This trial, which compared tirzepatide treatment to insulin glargine 100 U ml 1 treatment in people with T2D at increased cardiovascular risk, suggested no significant difference in the incidence of major cardiovascular events

The first and most established approach is lifestyle changes, which include diet and exercise

However, gastrointestinal adverse effects may limit its use for some patients

Obesity is a disease, and it reduces life span and compromises health. But given the expense to insurers, Dusetzina warned, if you expand the indications and extent of coverage, youll see premiums go up. For older patients, often underrepresented in clinical trials, questions about GLP-1s remain